TANDEMHEART
Device
LivaNova USA, Inc.
Total Payments
$260,779
Transactions
37
Doctors
26
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2023 | $260,779 | 37 | 26 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $258,635 | 10 | 99.2% |
| Food and Beverage | $2,144 | 27 | 0.8% |
Payments by Type
Research
$258,635
10 transactions
General
$2,144
27 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| TandemHeart Experiences and Methods THEME Registry | LivaNova USA, Inc. | $258,635 | 0 |
Ad
Manufacturing Companies
- LivaNova USA, Inc. $260,779
Product Information
- Type Device
- Total Payments $260,779
- Total Doctors 26
- Transactions 37
About TANDEMHEART
TANDEMHEART is a device associated with $260,779 in payments to 26 healthcare providers, recorded across 37 transactions in the CMS Open Payments database. The primary manufacturer is LivaNova USA, Inc..
Payment data is available from 2023 to 2023. In 2023, $260,779 was paid across 37 transactions to 26 doctors.
The most common payment nature for TANDEMHEART is "Unspecified" ($258,635, 99.2% of total).
TANDEMHEART is associated with 1 research study, including "TandemHeart Experiences and Methods THEME Registry" ($258,635).